We Handled
0Bn
Transferred
C Hedger
C Hedger
Pharmaceuticals
Pharmaceuticals
Currency management strategies for the pharmaceuticals sector
Overview
Since we started trading in 2018, we’ve helped many thousands of clients manage their currency exposures. This includes working with a robust roster of biomedical and pharmaceuticals companies, all of whom face a raft of specific economic and business challenges.
We Covered
0k
International transactions
A market facing significant risks
Biomedical and pharmaceutical companies face significant risks from economic, market and political developments. Income from products is often not 100% reliable (due to the government’s ability to stop the production of any drug immediately) and pharmaceutical companies particularly highlight the high research and development costs that they face. Furthermore, if a product’s patent comes to an end and starts to be produced by competitors, this massively slashes companies’ margins.
Streamlining processes
Our software sped up slow processes and reduced the risk of human error
Monitoring exposures
Currency Hedger helped track, manage and monitor currency exposures.
One-click management
The company was able to run reports and assess its hedging at the click of a button
Minimising exposure to risk and avoiding losses
Considering these significant industry risks, it is important for biomedical and pharmaceutical companies to minimise as many of these risks as possible. Some companies in the industry import a significant number of products, making them especially vulnerable to the impacts of currency market fluctuations. Currency Hedger helps these companies to mitigate foreign exchange risk by offering each company a bespoke strategy.
Cost Optimisation
24/5 Customer Support
Real Time Monitoring
Operational Excellence
